Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.52 USD | +10.01% | -5.31% | -22.86% |
07:57pm | Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate | MT |
02:00pm | Transcript : Intellia Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.86% | 2.06B | |
+48.64% | 54.63B | |
-6.44% | 39.92B | |
+37.07% | 38.82B | |
+14.28% | 26.86B | |
-11.17% | 26.22B | |
-21.40% | 18.78B | |
+25.64% | 12.21B | |
+0.96% | 12.16B | |
+27.04% | 11.94B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Barclays Adjusts Intellia Therapeutics Price Target to $90 From $148, Maintains Overweight Rating